InvestSMART

Starpharma Holdings Limited (ASX: SPL) - Announcements

Current share price for SPL : $0.790 0.005 (0.63%)+

ASX company news and announcements for Starpharma Holdings Limited (SPL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Starpharma Holdings Limited (SPL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Starpharma Holdings Limited (SPL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Starpharma Holdings Limited (SPL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$333 Quarterly Activities Report & Appendix 4C 30 Jan 2023 9:50AM $0.655 $0.790 risen by 20.61%
$333 Response to ASX Query Letters 12 Jan 2023 11:56AM $0.675 $0.790 risen by 17.04%
$333 Starpharma receives $7.1M R&D tax incentive refund 23 Dec 2022 8:28AM $0.515 $0.790 risen by 53.40%
$333 Resignation of CFO / Company Secretary 21 Dec 2022 12:13PM $0.515 $0.790 risen by 53.40%
$333 VIRALEZE Nasal Spray Registered in Indonesia 14 Dec 2022 11:04AM $0.530 $0.790 risen by 49.06%
$333 Positive AZD0466 clinical data presented by AstraZeneca 13 Dec 2022 11:08AM $0.518 $0.790 risen by 52.66%
$333 VIRALEZE Post-Market Clinical Study in COVID-19 Patients 8 Dec 2022 9:36AM $0.525 $0.790 risen by 50.48%
$333 Change in Director's Interest Notice - J Fairley 5 Dec 2022 3:38PM $0.528 $0.790 risen by 49.76%
$333 Notification regarding unquoted securities - SPL 5 Dec 2022 3:32PM $0.528 $0.790 risen by 49.76%
$333 Retirement of non-executive Director 30 Nov 2022 2:36PM $0.505 $0.790 risen by 56.44%
$333 AGM Results 29 Nov 2022 4:42PM $0.510 $0.790 risen by 54.90%
$333 AGM Chairman address and CEO presentation 29 Nov 2022 12:55PM $0.493 $0.790 risen by 60.41%
$333 VIRALEZE launched in Hong Kong and Macau 21 Nov 2022 9:58AM $0.530 $0.790 risen by 49.06%
$333 Starpharma to present at Bell Potter Healthcare Conference 8 Nov 2022 10:53AM $0.510 $0.790 risen by 54.90%
$333 Change in Director's Interest Notice - R Thomas 31 Oct 2022 12:45PM $0.520 $0.790 risen by 51.92%
$333 Change in Director's Interest Notice - J Fairley 31 Oct 2022 12:40PM $0.520 $0.790 risen by 51.92%
$333 Notice of Annual General Meeting/Proxy Form 28 Oct 2022 2:23PM $0.538 $0.790 risen by 46.98%
$333 Application for quotation of securities - SPL 27 Oct 2022 2:42PM $0.550 $0.790 risen by 43.64%
$333 Notification regarding unquoted securities - SPL 27 Oct 2022 2:40PM $0.550 $0.790 risen by 43.64%
$333 Quarterly Activities Report & Appendix 4C 26 Oct 2022 9:57AM $0.570 $0.790 risen by 38.60%
$333 VIRALEZE distribution agreement for Hong Kong and Macau 21 Oct 2022 9:42AM $0.600 $0.790 risen by 31.67%
$333 Change in substantial holding 21 Oct 2022 8:18AM $0.600 $0.790 risen by 31.67%
$333 Change in Director's Interest Notice - J Fairley 7 Oct 2022 1:17PM $0.670 $0.790 risen by 17.91%
$333 Notification of cessation of securities - SPL 7 Oct 2022 1:12PM $0.670 $0.790 risen by 17.91%
$333 Board Renewal 5 Oct 2022 1:18PM $0.588 $0.790 risen by 34.47%

201 - 225 of 866 results

Page 9 of 35

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.